Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bioventus Inc Cl A
(NQ:
BVS
)
9.920
+0.040 (+0.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bioventus Inc Cl A
< Previous
1
2
3
Next >
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
August 07, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Reports Second Quarter Financial Results
August 06, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 02, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
July 30, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Reports First Quarter Financial Results
May 07, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
April 29, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
March 12, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
March 04, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
February 12, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
January 18, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
January 12, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
December 26, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Bioventus Names Robert Claypoole as President and Chief Executive Officer
December 19, 2023
Seasoned Leader Brings More than Two Decades of Medical Device Experience and Proven Track Record of Driving Revenue and Operating Margin Growth
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
December 06, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
November 07, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Present at the Cantor Global Healthcare Conference
September 19, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
August 08, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
August 04, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
August 01, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Completes Divestiture of its Wound Business
May 23, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Reports First Quarter Financial Results
May 16, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
May 15, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
May 11, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Announces Divestiture of its Wound Business
May 10, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
May 03, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Inc. (NASDAQ:BVS) Long Term Investor Notice: Investigation of Potential Wrongdoing
April 25, 2023
San Diego, CA -- (SBWIRE) -- 04/25/2023 -- An investigation was announced for long-term investors in shares of Bioventus Inc. (NASDAQ:BVS) concerning potential breaches of fiduciary duties by certain...
Via
SBWire
Bioventus Announces CEO Leadership Change
April 05, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
March 31, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
March 31, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.